ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2182

Levels of Severity of Hip and Knee OA – Validation of Lay Descriptions

Marita Cross1, Willy Ngueyon Sime2, Francis Guillemin2 and Lyn March3, 1Northern Clinical School, Institute of Bone and Joint Research, Kolling Institute, University of Sydney & Department of Rheumatology, Royal North Shore Hospital, St Leonards NSW, Australia, 2University of Lorraine, Nancy, France, 3Department of Rheumatology, Northern Clinical School, Institute of Bone and Joint Research, Kolling Institute, University of Sydney & Department of Rheumatology, Royal North Shore Hospital, St Leonards, Sydney, Australia

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: osteoarthritis and severity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Epidemiology and Public Health - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Estimating the proportion of the population with severe OA is useful for health service planning. To calculate the proportion of the population with mild, moderate or severe OA, the Global Burden of Disease 2010 Study (GBD2010) used published WOMAC scores. From this, the proportion of the population in high income countries with mild OA was estimated as 71%, moderate 27% and severe 2%. Lay descriptions of levels of severity of OA were developed for GBD2010. If these are accurate measures of disease severity, these descriptions would be useful additions to population-based health questionnaires or brief assessments in clinical practice. The aim of this study is to validate lay descriptions of mild, moderate and severe OA and determine the proportion of a cohort within each category.

Methods: The descriptions were presented to the KHOALA cohort comprising OA knee and hip prevalent cases recruited as a representative sample of French patients with clinical and radiographic OA. Participants indicated which description they felt best described their condition. An additional level of “No pain or disability” was added for this cohort. Mild OA was described as “Has pain in the leg, which causes some difficulty running, walking long distances, and getting up and down” Moderate OA: “Has moderate pain in the leg, which makes the person limp, and causes some difficulty walking, standing, lifting and carrying heavy things, getting up and down and sleeping” Severe OA: “Has severe pain in the leg, which makes the person limp and causes a lot of difficulty walking, standing, lifting and carrying heavy things, getting up and down, and sleeping” Participants also completed WOMAC, EQ5D, EUROQOL VAS and walking times.

Results: Currently, 307 participants have completed the questionnaire with results shown in the table below. There was a significant trend for the WOMAC, EQ5D, EUROQOL and Maximal walking time to decline as the self-reported level of severity moved from none through mild and moderate to severe. The lay descriptions show significant convergent and divergent validity with the standardized measures used.

Conclusion: These preliminary results suggest that the lay descriptions are understandable by participants in this cohort. Those who rated their condition as consistent with the severe description also scored worse on the measures of pain and function. 14% classified themselves as having severe OA, in contrast to GBD2010, where only 2% were classified as severe OA. The burden of OA may in fact be greater than reported in GBD2010 as the proportion of the population living with more severe disease may have been underestimated. Further assessment is being undertaken with a larger sample of the KHOALA cohort. These lay descriptions may be useful as a brief starting point for discussions in clinical care, or a contribution to the assessment of severity of OA.


Disclosure: M. Cross, None; W. Ngueyon Sime, None; F. Guillemin, None; L. March, None.

To cite this abstract in AMA style:

Cross M, Ngueyon Sime W, Guillemin F, March L. Levels of Severity of Hip and Knee OA – Validation of Lay Descriptions [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/levels-of-severity-of-hip-and-knee-oa-validation-of-lay-descriptions/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/levels-of-severity-of-hip-and-knee-oa-validation-of-lay-descriptions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology